Parexel International Stock Hits New 52-Week High (PRXL)

NEW YORK ( TheStreet) -- Parexel International Corporation (Nasdaq: PRXL) hit a new 52-week high Wednesday as it is currently trading at $28.09, above its previous 52-week high of $27.91 with 50,070 shares traded as of 9:35 a.m. ET. Average volume has been 415,700 shares over the past 30 days.

Parexel International has a market cap of $1.24 billion and is part of the health care sector and health services industry. Shares are up 31.4% year to date as of the close of trading on Tuesday.

PAREXEL International Corporation, a biopharmaceutical services company, provides a range of clinical research, medical communications, consulting, commercialization, and technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. The company has a P/E ratio of 46, above the average health services industry P/E ratio of 31.4 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Parexel International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Parexel International Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

If you liked this article you might like

With Hurricane Harvey, We Are in the Crosshairs of Volatility: Market Recon

EY's Greene Sees More Med Tech, CRO Deals Ahead

Stocks Lower as Crude Oil Slides on Supply Concerns

Stock Futures Narrowly Mixed as Oil Plunges to Fresh 2017 Low